Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12151
CALL
Beam Global
BEEM
$25.1M
| $37.3K | ﹤0.01% |
7,600
+5,100
| +204% | +$27.9K |
2021 Q1
14 quarters
|
|
12152
CALL
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
| $37.3K | ﹤0.01% |
1,300
+1,000
| +333% | +$27.3K |
2023 Q3
4 quarters
|
|
12153
Redwire
RDW
$2.65B
| $37.3K | ﹤0.01% |
5,430
-1,290
| -19% | -$8.52K |
2023 Q2
5 quarters
|
|
12154
CALL
News Corp Class A
NWSA
$15.4B
| $37.3K | ﹤0.01% |
1,400
-62,600
| -98% | -$1.7M |
2022 Q4
7 quarters
|
|
|
BBU
12155
PUT
DELISTED
Brookfield Business Partners
BBU
| $37.3K | ﹤0.01% |
+1,600
| New | +$32.6K |
2024 Q3
0 quarters
|
|
|
SPNS
12156
PUT
DELISTED
Sapiens International
SPNS
| $37.3K | ﹤0.01% |
1,000
-1,000
| -50% | -$36.4K |
2023 Q4
3 quarters
|
|
12157
PUT
Chesapeake Utilities
CPK
$3.23B
| $37.3K | ﹤0.01% |
300
-200
| -40% | -$23.4K |
2022 Q4
7 quarters
|
|
|
AMPS
12158
PUT
DELISTED
Altus Power
AMPS
| $37.2K | ﹤0.01% |
11,700
+1,100
| +10% | +$3.92K |
2022 Q3
8 quarters
|
|
12159
PUT
Village Farms International
VFF
$341M
| $37.2K | ﹤0.01% |
40,000
-5,500
| -12% | -$5.62K |
2019 Q1
22 quarters
|
|
12160
PUT
Global X Russell 2000 Covered Call ETF
RYLD
$1.33B
| $37.2K | ﹤0.01% |
+2,300
| New | +$36.8K |
2024 Q3
0 quarters
|
|
|
OGI
12161
PUT
Organigram Holdings
OGI
$140M
| $37.1K | ﹤0.01% |
20,500
+12,200
| +147% | +$21.2K |
2021 Q1
14 quarters
|
|
12162
CALL
Limoneira
LMNR
$221M
| $37.1K | ﹤0.01% |
1,400
-2,700
| -66% | -$62K |
2023 Q4
3 quarters
|
|
12163
Kiora Pharmaceuticals
KPRX
$11.1M
| $37K | ﹤0.01% |
+10,114
| New | +$39.5K |
2024 Q3
0 quarters
|
|
12164
PUT
Stellus Capital Investment Corp
SCM
$208M
| $37K | ﹤0.01% |
2,700
+200
| +8% | +$2.77K |
2022 Q4
7 quarters
|
|
12165
CALL
DocGo
DCGO
$35.8M
| $36.9K | ﹤0.01% |
11,100
-5,300
| -32% | -$18K |
2022 Q1
10 quarters
|
|
12166
PUT
Donaldson
DCI
$10.4B
| $36.9K | ﹤0.01% |
500
-2,100
| -81% | -$152K |
2022 Q4
7 quarters
|
|
12167
Marker Therapeutics
MRKR
$16.8M
| $36.8K | ﹤0.01% |
+13,032
| New | +$51.5K |
2024 Q3
0 quarters
|
|
|
OLO
12168
CALL
DELISTED
Olo Inc
OLO
| $36.7K | ﹤0.01% |
7,400
+1,100
| +17% | +$5.44K |
2021 Q2
13 quarters
|
|
12169
CALL
Smart Sand
SND
$226M
| $36.6K | ﹤0.01% |
18,600
-18,500
| -50% | -$38.1K |
2021 Q1
14 quarters
|
|
12170
PUT
Associated Banc-Corp
ASB
$5.46B
| $36.6K | ﹤0.01% |
1,700
-2,900
| -63% | -$63K |
2023 Q1
6 quarters
|
|
|
SPRB
12171
Spruce Biosciences
SPRB
$123M
| $36.6K | ﹤0.01% |
1,027
-103
| -9% | -$3.77K |
2020 Q4
15 quarters
|
|
|
SLAI
12172
DELISTED
SOLAI Ltd ADS
SLAI
| $36.5K | ﹤0.01% |
2,219
+1,792
| +420% | +$31.5K |
2024 Q2
1 quarter
|
|
12173
CALL
Comstock
LODE
$172M
| $36.5K | ﹤0.01% |
+7,710
| New | +$17.8K |
2024 Q3
0 quarters
|
|
12174
PUT
Gold Royalty Corp
GROY
$688M
| $36.4K | ﹤0.01% |
26,800
+21,000
| +362% | +$28.5K |
2021 Q2
13 quarters
|
|
|
SBDS
12175
PUT
DELISTED
Solo Brands Inc
SBDS
| $36.4K | ﹤0.01% |
645
-55
| -8% | -$3.91K |
2022 Q2
9 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.